Targeting inflammation and cell death in injured knees
Imaging and therapeutic targeting of tissue crosstalk in the injured knee
This study is looking at how knee injuries can lead to arthritis later on, especially by exploring how inflammation and cell death work together, with the hope of finding new ways to help keep your knees healthy and avoid the need for replacements.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11056006 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind posttraumatic osteoarthritis (PTOA) that can occur after knee injuries, particularly focusing on the roles of inflammation and cell death. The team aims to understand how these two processes interact and contribute to ongoing joint damage. By studying both in laboratory settings and in animal models, they hope to identify new treatment strategies that can effectively restore joint health after injury. The ultimate goal is to develop therapies that can prevent the progression of PTOA, reducing the need for knee replacements in younger patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have suffered an anterior cruciate ligament (ACL) injury and are at risk of developing posttraumatic osteoarthritis.
Not a fit: Patients who have not experienced knee injuries or those with advanced osteoarthritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve joint health and quality of life for individuals with knee injuries.
How similar studies have performed: Other research has shown promise in targeting inflammation and apoptosis in joint injuries, suggesting that this approach could lead to meaningful advancements in treatment.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Ruiz Garzon, Maria Amparo — New York University School of Medicine
- Study coordinator: Ruiz Garzon, Maria Amparo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.